Halle-Pannenko O, Pritchard L L, Rappaport H
Transplantation. 1983 Jul;36(1):60-8.
Incompatibility for DBA/2 (D2) minor histocompatibility antigens (MiHA) alone leads to a severe lethal graft-versus-host reaction (GVHR) in adult (D2 X B10.D2)F1 recipients of B10.D2 bone marrow and spleen cells. In this genetic combination, mortality is completely abrogated by preimmunization of the graft donor against unrelated H-2b antigens and specific D2 MiHA a short time before grafting. Protection against GVHR mortality is elicited by immunizing the donors with a single transfusion of incompatible spleen cells or whole blood. Abrogation of GVHR mortality is due mainly to the immunization with specific MiHA, and only to a much lesser degree to the immunization with unrelated H-2 antigens; the protective effect induced by association of these two types of immunization, however, is significantly better than that elicited by either type of immunization alone. It is unlikely that this abrogation of GVHR mortality results from "dilution" of specifically reactive cells; rather, suppressor cells appear to be a contributing factor, because the preimmunization activates, in the donor spleen, suppressor cells capable of decreasing the severity of the GVHR developed against MiHA by normal cells. Histopathologic observations indicated that the lesions induced in various tissues after grafting of preimmunized donor cells were considerably less severe than those induced by grafting of normal donor cells. However, simultaneous immunization with specific MiHA and unrelated H-2 antigens may also exacerbate the GVHR, depending upon the conditions used for preimmunization; abrogation of GVHR mortality is favored by a single immunization with unrelated H-2b antigens and specific MiHA administered simultaneously a short time before grafting, whereas an acceleration of GVHR mortality is favored by long intervals and multiple immunizations. It is suggested that, depending upon the conditions used for the preimmunization, the allogeneic effect produced by stimulation with unrelated H-2 antigens may augment the response to MiHA or it may enhance the activation of suppressor cells that contribute to the abrogation of GVHR mortality.
单独针对DBA/2(D2)次要组织相容性抗原(MiHA)的不相容性会在成年(D2×B10.D2)F1受体接受B10.D2骨髓和脾细胞后引发严重的致死性移植物抗宿主反应(GVHR)。在这种基因组合中,通过在移植前短时间对移植物供体进行针对不相关H-2b抗原和特异性D2 MiHA的预先免疫,死亡率可完全消除。通过用不相容的脾细胞或全血单次输血免疫供体可引发对GVHR死亡率的保护作用。GVHR死亡率的消除主要归因于特异性MiHA的免疫,而仅在较小程度上归因于不相关H-2抗原的免疫;然而,这两种免疫联合诱导的保护作用明显优于单独任何一种免疫所引发的保护作用。GVHR死亡率的这种消除不太可能是由于特异性反应性细胞的“稀释”导致的;相反,抑制细胞似乎是一个促成因素,因为预先免疫在供体脾脏中激活了能够降低正常细胞针对MiHA产生的GVHR严重程度的抑制细胞。组织病理学观察表明,预先免疫的供体细胞移植后在各种组织中诱导的病变比正常供体细胞移植诱导的病变严重程度要低得多。然而,根据预先免疫所采用的条件,同时用特异性MiHA和不相关H-2抗原进行免疫也可能加剧GVHR;在移植前短时间同时给予不相关H-2b抗原和特异性MiHA进行单次免疫有利于消除GVHR死亡率,而长时间间隔和多次免疫则有利于加速GVHR死亡率。有人提出,根据预先免疫所采用的条件,由不相关H-2抗原刺激产生的同种异体效应可能增强对MiHA的反应,或者它可能增强有助于消除GVHR死亡率的抑制细胞的激活。